Precision Medicine in Childhood Asthma [post]

Javier Perez-Garcia, Esther Herrera-Luis, Fabian Lorenzo-Diaz, Mario A. Gonzalez Carracedo, Olaia Sardon Prado, Jesús Villar, Maria Pino-Yanes
2020 unpublished
Asthma is a complex and multifactorial respiratory disease with a high prevalence in the pediatric population. Variation in treatment response to asthma therapies has been described among patients, and difficult-to-treat asthma carries both high healthcare and socioeconomic burden to the patients and society. Omic studies can be used to discover the molecular mechanisms underlying asthma susceptibility and treatment response, contributing to a better knowledge and definition of asthma
more » ... tion of asthma pathogenesis and therefore, to the development of precision medicine. This entry aims to summarize the recent findings of omic studies of treatment response in childhood asthma. Between 2018-2019 a total of 13 omic studies has been performed involving genomics, epigenomics, transcriptomics, metabolomics, and the microbiome. These have been focused on the response to three common asthma medications: short-acting beta agonists, inhaled corticosteroids, and leukotriene receptor antagonists. Novel associations of different biomarkers with asthma treatment response have been described. However, stronger evidence and more consistent results are required to implement these molecular biomarkers into clinical practice by establishing the most appropriate therapy for each patient.
doi:10.32545/encyclopedia202005.0007.v3 fatcat:tlxttuljzvh6ldchci7fgwo6ze